Literature DB >> 3094691

Cytotoxic chemotherapy for common adult malignancies: "the emperor's new clothes" revisited?

J H Kearsley.   

Abstract

Entities:  

Mesh：

Year:  1986        PMID： 3094691      PMCID： PMC1341646          DOI： 10.1136/bmj.293.6551.871

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  54 in total

1.  Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland.

Authors:  J L Hayward; P P Carbone; J C Heuson; S Kumaoka; A Segaloff; R D Rubens
Journal:  Cancer       Date:  1977-03       Impact factor: 6.860

2.  Cancer chemotherapy--what have we achieved?

Authors:  R A Milsted; M H Tattersall; R M Fox; R L Woods
Journal:  Lancet       Date:  1980-06-21       Impact factor: 79.321

Review 3.  The chemotherapy of prostatic adenocarcinoma.

Authors:  F M Torti; S K Carter
Journal:  Ann Intern Med       Date:  1980-05       Impact factor: 25.391

4.  Survival and response to chemotherapy for advanced colorectal adenocarcinoma: an Eastern Cooperative Oncology Group report.

Authors:  P Lavin; A Mittelman; H Douglass; P Engstrom; D Klaassen
Journal:  Cancer       Date:  1980-10-01       Impact factor: 6.860

5.  Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx.

Authors:  J T Fazekas; C Sommer; S Kramer
Journal:  Int J Radiat Oncol Biol Phys       Date:  1980-05       Impact factor: 7.038

6.  Chemotherapy of hormone-resistant stage D prostatic cancer.

Authors:  J D Schmidt
Journal:  J Urol       Date:  1980-06       Impact factor: 7.450

7.  Chemotherapy of metastatic bladder cancer.

Authors:  A Yagoda
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

8.  Chemotherapy of disseminated breast cancer. Current status and prospects.

Authors:  P P Carbone; M Bauer; P Band; D Tormey
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

9.  Adjuvant chemotherapy for breast cancer: side effects and quality of life.

Authors:  B V Palmer; G A Walsh; J A McKinna; W P Greening
Journal:  Br Med J       Date:  1980-12-13

10.  Results of a prospective randomized study of hepatic artery infusion with 5-fluorouracil versus intravenous 5-fluorouracil in patients with hepatic metastases from colorectal cancer: A Central Oncology Group study.

Authors:  T B Grage; P P Vassilopoulos; W W Shingleton; A V Jubert; E G Elias; J B Aust; S E Moss
Journal:  Surgery       Date:  1979-10       Impact factor: 3.982
View more
  5 in total

Review 1.  Palliative medicine.

Authors:  R J George; A L Jennings
Journal:  Postgrad Med J       Date:  1993-06       Impact factor: 2.401

Review 2.  Can cancer chemotherapy enhance the malignant behaviour of tumours?

Authors:  T J McMillan; I R Hart
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries.

Authors:  M Quinn; E Allen
Journal:  BMJ       Date:  1995-11-25

4.  Presidential address at the European Society for Medical Oncology, Nice, 30 November 1986.

Authors:  S Monfardini
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

5.  Hospice management of patients receiving cytotoxic chemotherapy: problems and opportunities.

Authors:  F Hicks; G Corcoran
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.